Jeffrey Immelt - Bright Health Independent Director
| BHGDelisted Stock | USD 12.29 0.39 3.08% |
Insider
Jeffrey Immelt is Independent Director of Bright Health Group since 2020.
| Age | 64 |
| Tenure | 4 years |
| Phone | 612 238 1321 |
| Web | https://www.brighthealthgroup.com |
Jeffrey Immelt Latest Insider Activity
Tracking and analyzing the buying and selling activities of Jeffrey Immelt against Bright Health stock is an integral part of due diligence when investing in Bright Health. Jeffrey Immelt insider activity provides valuable insight into whether Bright Health is net buyers or sellers over its current business cycle. Note, Bright Health insiders must abide by specific rules, including filing SEC forms every time they buy or sell Bright Health'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Jeffrey Immelt over two months ago Acquisition by Jeffrey Immelt of 2722 shares of Bloom Energy at 10.56 subject to Rule 16b-3 |
Bright Health Management Efficiency
The company has Return on Asset of (0.0701) % which means that on every $100 spent on assets, it lost $0.0701. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (1.1855) %, meaning that it generated no profit with money invested by stockholders. Bright Health's management efficiency ratios could be used to measure how well Bright Health manages its routine affairs as well as how well it operates its assets and liabilities.Bright Health Group has 303.95 M in debt with debt to equity (D/E) ratio of 0.02, which may show that the company is not taking advantage of profits from borrowing. Bright Health Group has a current ratio of 0.85, suggesting that it has not enough short term capital to pay financial commitments when the payables are due. Note however, debt could still be an excellent tool for Bright to invest in growth at high rates of return.
Similar Executives
| Showing other executives | INSIDER Age | ||
| Ronald Penczek | Elevance Health | 59 | |
| Raquel Bono | Humana Inc | 64 | |
| Jim Murray | Centene Corp | N/A | |
| Jonathan Dinesman | Centene Corp | N/A | |
| Neesha Hathi | Cigna Corp | 47 | |
| Jorge Mesquita | Humana Inc | 59 | |
| William Roper | Cigna Corp | 71 | |
| Rob Scavo | Alignment Healthcare LLC | N/A | |
| Amy Fry | Humana Inc | N/A | |
| Kathleen Mazzarella | Cigna Corp | 61 | |
| Leslie Norwalk | Centene Corp | 55 | |
| Cynthia Ryan | Cigna Corp | 50 | |
| Sue Schick | Humana Inc | N/A | |
| Ashlee Knuckey | Centene Corp | N/A | |
| John Garratt | Humana Inc | 52 | |
| Andrew Toy | Clover Health Investments | 45 | |
| Laurie Havanec | CVS Health Corp | 63 | |
| Gloria McCarthy | Elevance Health | 71 | |
| Patricia Lewis | UnitedHealth Group Incorporated | 57 | |
| Marc Russo | Molina Healthcare | 54 | |
| Charles Berg | Cigna Corp | 63 | |
Management Performance
| Return On Equity | -1.19 | |||
| Return On Asset | -0.0701 |
Bright Health Group Leadership Team
Elected by the shareholders, the Bright Health's board of directors comprises two types of representatives: Bright Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Bright. The board's role is to monitor Bright Health's management team and ensure that shareholders' interests are well served. Bright Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Bright Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Simeon Schindelman, Chief Executive Officer of Bright HealthCare | ||
| Matthew Manders, Independent Director | ||
| Jeffrey Folick, Independent Director | ||
| Megan North, President NeueSolutions | ||
| Stephen Kraus, Independent Director | ||
| Jeffrey Scherman, Chief Officer | ||
| Mohamad Makhzoumi, Independent Director | ||
| Jay Matushak, Chief Officer | ||
| Tomas Valdivia, Co-Founder, Chief Health and Equity Officer | ||
| Joaquin MD, President Care | ||
| Tomas Orozco, Executive Care | ||
| Adair Newhall, Independent Director | ||
| Catherine Smith, Chief Financial and Administrative Officer | ||
| Jeffrey Immelt, Independent Director | ||
| Brett Erhardt, Chief Officer | ||
| Kedrick Adkins, Independent Director | ||
| Linda Gooden, Independent Director | ||
| G Mikan, President, Chief Executive Officer, Director | ||
| Tomas MS, CoFounder Officer | ||
| Keith Nelsen, General Counsel, Corporate Secretary | ||
| George III, CEO Chairman | ||
| Jeff Craig, General Counsel, Corporate Secretary | ||
| Jeffrey Cook, Chief Officer | ||
| Sam Srivastava, Chief Executive Officer of NeueHealth | ||
| Stephen CFA, Director Relations | ||
| Stacy Conti, Chief Officer | ||
| Andrew Slavitt, Independent Director | ||
| Manuel Kadre, Independent Director | ||
| Bob Sheehy, Executive Chairman, Co-Founder | ||
| Mike Mikan, President, Chief Executive Officer | ||
| Naomi Allen, Independent Director | ||
| Robert Sheehy, Executive Chairman of the Board |
Bright Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Bright Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.19 | |||
| Return On Asset | -0.0701 | |||
| Profit Margin | (0.58) % | |||
| Operating Margin | (0.21) % | |||
| Current Valuation | 1.25 B | |||
| Shares Outstanding | 7.98 M | |||
| Shares Owned By Insiders | 4.93 % | |||
| Shares Owned By Institutions | 65.02 % | |||
| Number Of Shares Shorted | 104.17 K | |||
| Price To Book | 0.95 X |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Other Consideration for investing in Bright Stock
If you are still planning to invest in Bright Health Group check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Bright Health's history and understand the potential risks before investing.
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |